Analysis of fibroblast growth factor receptor 3 S249C mutation in cervical carcinoma

Journal of the National Cancer Institute

Volumn 92, Issue 22, 2000, Pages 1848-1849

  Yee, Cindy J ^a   Lin, Oscar ^a   Boyd, Jeff ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 19Q; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 5P; CHROMOSOME 6P; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; UTERINE CERVIX CARCINOMA;

EID: 0034669061     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.22.1848     Document Type: Article

References (11)

1. Estimates of the worldwide incidence of 25 major cancers in 1990
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. The molecular genetics of cervical carcinoma
4. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
5. The FGF family of growth factors and oncogenes
6. Structural and functional diversity in the FGF receptor multigene family
7. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction
8. Fibroblast-growth-factor receptor mutations in human skeletal disorders
9. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
10. P53 polymorphism and risk of cervical cancer